in vitro studies showed that cefotaxime and amikacin were active against 78.7 and 94.7 % of the pathogens , respectively , despite the high frequency ( 31 % ) of multiply resistant strains of pseudomonas aeruginosa ( defined as in vitro simultaneously resistant to carbenicillin , gentamicin , tobramycin and sisomicin ) isolated from blood and infected sites .
C0017436
gentamicin
C0037209
sisomicin